NSE filing, NSE: TI. Summary written from the filing by ALFA Finder's alert engine.
Tilaknagar Industries Ltd: key numbers
- Share price
- ₹503.55
- Market cap
- ₹12,483 Cr
- Revenue (annual)
- ₹2,346 Cr
- Net profit (annual)
- ₹20.87 Cr
- P/E (TTM)
- -346.3×Sector 26.2×
- Promoter holding
- 31.62%-0.06% QoQ
- FII holding
- 17.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tilaknagar Industries Ltd
All →Tilaknagar Industries Board Meeting Date
Tilaknagar Industries will hold a board meeting on 30 October 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window has been closed since 1 October 2026.
Tilaknagar Industries ED Probe / Tax Survey
Tilaknagar Industries disclosed a DRI customs search of its offices and plant on October 22, 2026. It reports no financial impact so far.
Tilaknagar Industries Other Announcement
Tilaknagar Industries filed the mandatory quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Tilaknagar Industries Management Change
Mr. Rajesh Choudhary has resigned as Chief Financial Officer. The company has appointed Deputy CFO Mr. Anil Singal as Senior Management Personnel for finance oversight.
Tilaknagar Industries Management Change
Tilaknagar Industries re-appointed Amit Dahanukar as Chairman and Managing Director, and Chemangala Ramachar Ramesh as Whole-Time Director. Additionally, Bhumika Batra's designation changed to Non-Executive Independent Director.
Tilaknagar Industries Annual General Meeting
Tilaknagar Industries Ltd held its 91st Annual General Meeting on September 22, 2026. The meeting transacted business including financial adoption, dividend declaration, and director appointments.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.